• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
    • BOD
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
Financials ofSubsidiary
Year ended March 31st 2017
FinancialDownloadYear ended March 31st 2018
FinancialDownloadYear ended March 31st 2019
FinancialDownloadYear ended March, 2020
FinancialDownloadYear Ended March 31st, 2021
FinancialDownloadYear Ended March 31st, 2022
FinancialDownloadYear Ended March 31st, 2023
FinancialDownloadYear Ended March 31st, 2024
FinancialDownload
Copyrights Reserved 2008-2025. Naxpar Group